G protein-coupled receptors (GPCRs) are the most commonly exploited target in modern medicine; however, they have historically not been targeted in oncology.  Recently, researchers have identified opportunities for targeting GPCRs in oncology, resulting in increased focus by drug developers in using GPCRs as targets in oncology.  This article provides background information on GPCRs as drug…